Large Blog Layout

All Time Classic Layout
CLB Leading the Way to Affordable Therapeutics 2560 1029 CL Biologics

CLB Leading the Way to Affordable Therapeutics

Q & A with Dr. John Zhang, COO of CL Biologics Question: What is CLB’s organizational goal? At CL Biologics (CLB), our goal is to provide affordable medicines to the world, that meet or exceed the regulatory expectation of every…

read more
Primer on Biomanufacturing 4.0 1195 380 CL Biologics

Primer on Biomanufacturing 4.0

Biomanufacturing 4.0 is a technology that is revolutionizing the way pharmaceuticals are produced. This new technology utilizes oversized stainless steel bioreactors for the efficient production of antibody drugs. These bioreactors are designed to enable robust, cost-effective and scalable production of…

read more
biologics CDMO eQMS
CLB launches digital Quality Management Suites 2000 797 CL Biologics

CLB launches digital Quality Management Suites

September 22, 2022, Shenzhen – CL Biologics (CLB) announces today at the CLB Watson Center for Life Sciences and Technology the launch of its digital Quality Management Suites (eQMS), integrating three key quality systems: TrackWise®, Documentum® and ComplianceWire®. Under the…

read more
Industry 4.0 in Biologics Manufacturing 1195 380 CL Biologics

Industry 4.0 in Biologics Manufacturing

In recent years, the application of the Industry 4.0 framework has become increasingly popular in biologics manufacturing. By utilizing the latest digital technologies, biologic manufacturers can create more efficient, cost-effective, and higher-quality products to meet the needs of their customers.…

read more